Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 71 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Stimulant-Use Disorder Clear all

Conditions: HIV, Stimulant Use Disorder, Justice Involved Populations, HIV Prevention
Interventions: DynamiCare, Patient Navigation (PN); Device · Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: New Haven, Connecticut • Dallas, Texas

Conditions: Methamphetamine Use Disorder, Substance-Related Disorders, Chemically-Induced Disorders, Substance Use Disorders, Stimulant-Use Disorder
Interventions: Psilocybin; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 25 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Stimulant Use, Stimulant-Related Disorder, Healthy
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Methamphetamine Use Disorder
Interventions: care navigation; Behavioral
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years and older
Enrollment: 192 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Opioid Use, Stimulant Use
Interventions: harm reduction intervention; Behavioral
Lead sponsor: Brittany Miller-Roenigk; Other
Eligibility: 18 Years to 65 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 3
States / cities: Louisville, Kentucky • Cincinnati, Ohio

Conditions: Opioid Abuse (Disorder), Stimulant Use Disorders
Interventions: Patient Navigation; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Female only
Enrollment: 429 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Stimulant Use, Relapse, Cognitive Function, ADHD
Interventions: Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Amphetamine-Related Disorders
Interventions: Psilocybin, Treatment-as-usual; Drug · Behavioral
Lead sponsor: Portland VA Research Foundation, Inc; Other
Eligibility: 25 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Vancouver, Washington

Conditions: Stimulant Use Disorder
Interventions: SUVO, TAU; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stimulant Use (Diagnosis)
Interventions: Science to Service Laboratory; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 9
States / cities: Chicago, Illinois • Rockford, Illinois • Pawtucket, Rhode Island + 1 more

Conditions: Stimulant Use (Diagnosis), Hiv
Interventions: Contingency management; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cocaine Dependence, Methamphetamine Dependence, Nicotine Dependence
Interventions: Smoking-cessation treatment; Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 538 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 12
States / cities: Tucson, Arizona • Rancho Cucamonga, California • Tarzana, California + 9 more

Conditions: Accidental Overdose of Opiate
Interventions: Overdose prevention resources, Overdose prevention education; Other · Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stimulant Use Disorder
Interventions: Smartphone digital therapeutic system; Device
Lead sponsor: DynamiCare Health; Industry
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Nicotine Dependence
Interventions: Intravenous Nicotine, Progesterone; Drug
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 40 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Substance Use Disorder (SUD), Opioid Use Disorders, Stimulant Overdose, Overdose Risk, Alcohol Use Disorder
Interventions: Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters), Recovery Management Checkups (RMC) delivered by staff under the research team (RMC by research staff); Behavioral
Lead sponsor: Chestnut Health Systems; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stimulant Use Disorder, Cocaine Use Disorder, Methamphetamine Use Disorder
Interventions: LDART, Psychoeducational booklet; Device · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Opioid Use Disorder, Stimulant Use Disorder
Interventions: Contingency Management; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Methamphetamine Use Disorder, Transcranial Magnetic Stimulation
Interventions: Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active, Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Sham; Device
Lead sponsor: Stanford University; Other
Eligibility: 25 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Prescription Drug Abuse (Not Dependent)
Interventions: Caffeine-Based Expectancy Challenge, Placebo-Based Expectancy Challenge; Behavioral
Lead sponsor: University of Wyoming; Other
Eligibility: 18 Years to 25 Years
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Laramie, Wyoming

Conditions: Opioid Use, Stimulant Use, Depression and Anxiety Symptoms
Interventions: uMAT-R + enhanced community engagement, Original uMAT-R supplementary mHealth recovery intervention; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Substance Use Disorders, Alcohol Use Disorder, Stimulant-Related Disorder
Interventions: Cognitive Behavioral Therapy, Standard CBT; Device · Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rochester, New York

Conditions: HIV Infections, Methamphetamine-dependence, Methamphetamine Abuse
Interventions: Not listed
Lead sponsor: Florida International University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Stimulant Use Disorder
Interventions: Mirtazapine, Placebo; Drug
Lead sponsor: Washington State University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Spokane, Washington

Search by objective public record fields.

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

The Longitudinal Study of Stimulant Use Disorder

Beginning Early and Assertive Treatment for Methamphetamine Use Disorder

THRIVE: Culturally AdapTed Harm Reduction Intervention

Optimizing Pregnancy and Treatment Interventions for Moms 3.0

Relapse Prevention in Stimulant Use Disorder

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations

Contingency Management in HIV Care for Both Stimulant Use & ART Adherence

Smoking-Cessation and Stimulant Treatment (S-CAST)

Remote Intervention to Prevent Overdose

Smartphone Services for Stimulant Use Disorder

Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect

Recovery Management Checkup Scalability and Sustainability Hybrid Experiment

LDART for Stimulant Use Disorder

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

Deep TMS of Neural Circuits Associated With Stimulant Use Disorder

Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use

Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City

A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT

Stimulant Use and Methylation in HIV

Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment